A detailed history of Hanover Advisors Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Hanover Advisors Inc holds 5,498 shares of RXST stock, worth $192,704. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,498
Previous 4,998 10.0%
Holding current value
$192,704
Previous $301 Million 9.63%
% of portfolio
0.11%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.78 - $57.04 $20,390 - $28,520
500 Added 10.0%
5,498 $272 Million
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $50,420 - $64,290
-1,000 Reduced 16.67%
4,998 $301 Million
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $212,988 - $347,404
5,998 New
5,998 $309 Million
Q4 2023

May 23, 2024

SELL
$20.91 - $40.9 $20,910 - $40,900
-1,000 Reduced 16.67%
4,998 $202 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $969M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Hanover Advisors Inc Portfolio

Follow Hanover Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanover Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanover Advisors Inc with notifications on news.